Better Medicine Secures €1M in Pre-Seed Funding for AI-Powered Diagnostic Tools
Key Points:
- Better Medicine, a startup based in Tartu, Estonia, has raised €1M in Pre-Seed funding to further develop its AI-powered diagnostic tools for radiology.
- The funding round was led by Soulmates Ventures, with participation from Specialist VC, UT Ventures, and angel investors, with plans to expand operations and research and development efforts.
- Better Medicine’s flagship product, BMVision Kidney, has received CE certification as a Class IIa medical device under the EU Medical Device Regulation, making it the first CE-certified, AI-based kidney cancer detection tool compliant with the regulation.
Better Medicine, a startup hailing from Tartu, Estonia, has recently secured €1M in Pre-Seed funding to propel the development of its AI-powered diagnostic tools tailored for radiology. The investment, spearheaded by Soulmates Ventures and supported by Specialist VC, UT Ventures, and angel investors, will enable the company to expand its operations and intensify its research and development endeavors.
Under the leadership of CEO and Founder Priit Salumaa, Better Medicine specializes in medical AI solutions, with a focus on developing CE-certified software tools to aid in cancer detection and diagnosis within radiology. The company’s BMVision platform seamlessly integrates into radiologists’ workflows, facilitating the detection and measurement of oncological findings, starting with kidney lesions.
Noteworthy is the recent CE certification of Better Medicine’s flagship product, BMVision Kidney, as a Class IIa medical device in compliance with the EU Medical Device Regulation. This milestone marks the first CE-certified, AI-based kidney cancer detection tool to meet regulatory standards, underscoring the company’s commitment to delivering cutting-edge solutions in the healthcare sector.
In addition to its technological advancements, Better Medicine has forged valuable clinical collaborations with esteemed partners such as Leeds Teaching Hospitals NHS Trust, Tartu University Hospital, Tartu University, and Pärnu Hospital. With a global team spanning six countries, encompassing diverse expertise in medical practice, research, computer science, and startup development, Better Medicine stands poised to revolutionize cancer diagnostics through innovative AI-driven solutions.
With a total of €2.25M in private funding and €3.7M in grants secured, totaling nearly €6M in funding overall, Better Medicine is well-positioned to drive advancements in the field of radiology and elevate the standard of care for patients worldwide.
